BioSpace News Archive

Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, announced global commercial availability for the four-channel TEG® 6s PlateletMapping® ADP & AA assay cartridge.

Dragonfly Therapeutics (“Dragonfly”), a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease, and AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced a multi-target research collaboration designed to advance a number of Dragonfly’s novel NK cell engager-based immunotherapies for autoimmune and oncology indications.

Phoenix Molecular Designs announced that it has completed its most recent round of seed financing, resulting in a total raised to date of $12M.

Medicenna Therapeutics Corp. announced that it will host a Key Opinion Leader call and webcast for the investment community on Monday, November 25, 2019 at 10:00 AM, ET.

In recognition of his distinguished career working as a senior investigator at Versiti Blood Research Institute for nearly 50 years, Richard Aster, M.D., was selected to receive the most prestigious award offered by the American Society of Hematology During its Annual Meeting, Dec. 7-10 in Orlando, Fla., ASH will honor Dr. Aster with the Wallace H. Coulter Award for Lifetime Achievement in Hematology.

errAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or “the Company”), the first and only global cannabis company licensed for sales in Canada, the U.S., and the EU, today reported financial results for the third quarter ending September 30, 2019

Massive Bio, a leader in Artificial Intelligence based oncology clinical trial enrollment, and The American Sexual Health Association, a leader in advancing the health of communities by improving awareness in sexual health, formed an exciting partnership to promote targeted clinical trials to cervical cancer patients – especially for those patients treated at community practices that have limited access to research opportunities.

Technology overcomes limitations of traditional and dual-energy X-Ray imaging, using a world first mobile 14”x17" cassette-sized detector. Reveal™ enables soft-tissue differentiation with a single exposure without motion artifacts

Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases, today announced that it has consummated a private investment from Polaris Partners, a leading healthcare investment firm with a long history of partnering with entrepreneurs in biotechnology

Zeteo Tech, Inc. announced the development of the Canine Auditory Protection System The project was developed in collaboration with Dr. Pete “Skip” Scheifele MD, PhD, LCDR USN of the University of Cincinnati.